title: The FDA warning on antidepressants and suicidality--why the controversy?
authors.affiliation: From the Food and Drug Administration, Silver Spring, MD.
authors.forename: Marc B
authors.initials: MB
authors.lastname: Stone
mesh_terms: D000293:Adolescent; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000506:poisoning / Q000627:therapeutic use; D002648:Child; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D004363:Drug Utilization / Q000639:trends*; D033161:Government Regulation; D006801:Humans; D011041:Poisoning / Q000453:epidemiology; D012307:Risk Factors; D013405:Suicide / Q000639:trends*; D014481:United States; D014486:United States Food and Drug Administration; D000092864:Suicide Prevention
chemical_list: D000928:Antidepressive Agents